Skip to main content

Clinical Trials Using Dacarbazine

Review the clinical trials studying dacarbazine on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-16 of 16

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Status: Active
Location: 339 locations
A Randomized Study Investigating Preoperative Chemotherapy Followed by Surgery versus Surgery Alone in Patients with High Risk Retroperitoneal Sarcoma, STRASS2 Trial
Status: Active
Location: 96 locations
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Status: Active
Location: 27 locations
IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
Status: Active
Location: 20 locations
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
Status: Active
Location: 20 locations
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Status: Active
Location: 7 locations
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Status: Active
Location: 12 locations
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)
Status: Active
Location: 13 locations
Brentuximab Vedotin in Early-Stage Hodgkin Lymphoma, RADAR Trial
Status: Active
Location: 5 locations
Fitness-Adapted, Pembrolizumab-Based Therapy for the Treatment of Untreated Classical Hodgkin Lymphoma in Patients 60 Years of Age and Above
Status: Active
Location: 3 locations
Cytoreductive Surgery with Gemcitabine Followed by Dacarbazine for the Treatment of Locally Recurrent Uterine Leiomyosarcoma
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
PET Adapted Treatment with Brentuximab Vedotin and Pembrolizumab in Combination with Doxorubicin and Dacarbazine for Advanced Classic Hodgkin Lymphoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Personalized Reduction of Chemotherapy Intensity through ctDNA Evaluation for the Treatment of Patients with Advanced Hodgkin Lymphoma
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Abbreviated Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone for the Treatment of Stage IIB-IV Hodgkin Lymphoma
Status: Active
Location: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
Status: Active
Location: University of Florida Health Science Center - Gainesville, Gainesville, Florida
Implantable Microdevice for the Delivery of Drugs and their Effect on Tumors in Patients with Sarcoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas